Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer

In patients with differentiated thyroid cancer, stimulated thyroglobulin (sTg) levels after thyroid hormone withdrawal (THW) at remnant ablation (RA) and at 6 to 12 months are known to have good prognostic value. This study aimed to evaluate the prognostic impacts and best cutoff values of sTg level...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Jeonghoon, Kim, Min Hee, Jo, Kwanhoon, Lim, Yejee, Bae, Ja Seong, Lee, Sohee, Kang, Moo Il, Cha, Bong Yun, Lim, Dong Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521902/
https://www.ncbi.nlm.nih.gov/pubmed/28723762
http://dx.doi.org/10.1097/MD.0000000000007512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521902/
https://www.ncbi.nlm.nih.gov/pubmed/28723762
http://dx.doi.org/10.1097/MD.0000000000007512

Ejemplares similares